Editorials
Adverse effects of statins
BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g3306 (Published 15 May 2014) Cite this as: BMJ 2014;348:g3306
Data supplement
Peer review for Abramson's article
Peer review for Abramson's article
Files in this Data Supplement:
- Peer review by Ruijter - Peer review by Ruijter
- Peer review by Smeeth - Peer review by Smeeth
Related articles
- Analysis Published: 22 October 2013; BMJ 347 doi:10.1136/bmj.f6123
- Observations Published: 22 October 2013; BMJ 347 doi:10.1136/bmj.f6340
- News Published: 04 August 2014; BMJ 349 doi:10.1136/bmj.g4993
- Letter Published: 11 June 2014; BMJ 348 doi:10.1136/bmj.g3652
- Letter Published: 11 June 2014; BMJ 348 doi:10.1136/bmj.g3650
- Letter Published: 11 June 2014; BMJ 348 doi:10.1136/bmj.g3724
- Letter Published: 18 June 2014; BMJ 348 doi:10.1136/bmj.g4030
- Letter Published: 18 June 2014; BMJ 348 doi:10.1136/bmj.g4028
- Letter Published: 09 July 2014; BMJ 349 doi:10.1136/bmj.g4130
- Letter Published: 15 July 2014; BMJ 349 doi:10.1136/bmj.g4385
- Editorial Published: 14 September 2016; BMJ 354 doi:10.1136/bmj.i4963
See more
- Semaglutide’s CVD indication could cost US Medicare $145bn extra a yearBMJ August 28, 2024, 386 q1878; DOI: https://doi.org/10.1136/bmj.q1878
- Semaglutide: UK regulator approves drug for prevention of cardiovascular eventsBMJ July 25, 2024, 386 q1660; DOI: https://doi.org/10.1136/bmj.q1660
- Why India is failing to track heatstroke fatalities properlyBMJ July 17, 2024, 386 q1437; DOI: https://doi.org/10.1136/bmj.q1437
- Mail on Sunday articles that accused three commentators of being “statin deniers” were misinformed, judge rulesBMJ June 26, 2024, 385 q1424; DOI: https://doi.org/10.1136/bmj.q1424
- Sixty seconds on . . . flyingBMJ June 10, 2024, 385 q1266; DOI: https://doi.org/10.1136/bmj.q1266
Cited by...
- The impact of health literacy-sensitive design and heart age in a cardiovascular disease prevention decision aid: randomised controlled trial and end user testing
- Shared decision-making about cardiovascular disease medication in older people: a qualitative study of patient experiences in general practice
- Online decision aids for primary cardiovascular disease prevention: systematic search, evaluation of quality and suitability for low health literacy patients
- A content analysis of the representation of statins in the British newsprint media
- Providing additional information about the benefits of statins in a leaflet for patients with coronary heart disease: a qualitative study of the impact on attitudes and beliefs
- Statins evidence: when answers also raise questions
- Patients who discontinued statin treatment: a protocol for cohort study using primary care data
- Dyslipidaemia and the military patient
- Statins and The BMJ
- Two papers in The BMJ with statin side effect errors shouldn't be retracted, independent panel concludes
- Information about diabetogenic effect of statins is inadequate in France
- Concerns about the latest NICE draft guidance on statins
- The BMJ statins papers misrepresent the facts
- Retraction of statins article is not in the public interest: better characterisation of benefits and risks is crucial
- (Mis)interpreting studies on the adverse effects of statins
- Urgent need to establish the true incidence of the side effects of statins
- Muscular adverse effects are common with statins